Ana Smolić
Ana Smolić has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ana Kovačević
Sestre milosrdnice University Hospital Center,Zagreb,Croatia, Croatia
1 shared publication - Anita Špehar Uroić
Children's Hospital Zagreb,Zagreb,Croatia, Croatia
1 shared publication - Bernardica Valent Morić
Sestre milosrdnice University Hospital Center,Zagreb,Croatia; School of Medicine,Catholic University of Croatia,Zagreb,Croatia, Croatia
1 shared publication - Lavinia La Grasta Sabolić
Sestre milosrdnice University Hospital Center,Zagreb,Croatia; School of Medicine,Catholic University of Croatia,Zagreb,Croatia, Croatia
1 shared publication - Lora Grbanović
Department of Radiology, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia
1 shared publication - Lucija Kovacevic
Department of Radiology, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia
1 shared publication
Latest Publications
- Open Access
- 11 May 2026
- Published by MDPI AG in Preprints.org
Impact of the Menstrual Cycle on Continuous Glucose Monitoring - Derived Glycemic Parameters in Adolescent Girls With Type 1 Diabetes: A Retrospective Observational Study
Background and Objectives: Emerging clinical data indicate that glucose levels in women with type 1 diabetes (T1D) fluctuate throughout the menstrual cycle. However, data concerning the adolescent population remain sparse. This study aimed to compare continuous glucose monitoring (CGM)-derived glycemic metrics between the early follicular and late luteal phases in adolescent girls with T1D in order to establish a clinical basis for phase-specific treatment adjustments. Materials and Methods: Ninety-nine menstrual cycles from 34 female adolescents with T1D were retrospectively analyzed. Time in range (TIR), time above range (TAR), time below range (TBR), mean glucose, and glucose variability were compared between the early follicular and late luteal phases. Additional analyses were performed to evaluate the impact of different insulin delivery methods and to assess glycemic metrics across subgroups by glycemic control. Results: During the late luteal phase, TIR was significantly lower, while TAR and mean glucose were significantly higher compared to the early follicular phase (p < 0.05). Although the continuous subcutaneous insulin infusion (CSII) group achieved better overall glycemic metrics then the multiple daily injections (MDI) group, phase-related fluctuations in TIR and TAR reached significance precisely within the CSII group. Furthermore, glycemic shifts in TAR, TBR and mean glucose were especially pronounced in adolescents with tight glycemic control (HbA1c < 7.0%). Conclusions: The late luteal phase is associated with significant glycemic deterioration in adolescent girls with T1D, particularly in those with optimal glycemic control. These findings underscore the need for targeted education and menstrual-cycle-tailored insulin dose adjustments.
- 11 May 2026
- Published by MDPI AG in Preprints.org
Open AccessImpact of the Menstrual Cycle on Continuous Glucose Monitoring - Derived Glycemic Parameters in Adolescent Girls With Type 1 Diabetes: A Retrospective Observational Study
Background and Objectives: Emerging clinical data indicate that glucose levels in women with type 1 diabetes (T1D) fluctuate throughout the menstrual cycle. However, data concerning the adolescent population remain sparse. This study aimed to compare continuous glucose monitoring (CGM)-derived glycemic metrics between the early follicular and late luteal phases in adolescent girls with T1D in order to establish a clinical basis for phase-specific treatment adjustments. Materials and Methods: Ninety-nine menstrual cycles from 34 female adolescents with T1D were retrospectively analyzed. Time in range (TIR), time above range (TAR), time below range (TBR), mean glucose, and glucose variability were compared between the early follicular and late luteal phases. Additional analyses were performed to evaluate the impact of different insulin delivery methods and to assess glycemic metrics across subgroups by glycemic control. Results: During the late luteal phase, TIR was significantly lower, while TAR and mean glucose were significantly higher compared to the early follicular phase (p < 0.05). Although the continuous subcutaneous insulin infusion (CSII) group achieved better overall glycemic metrics then the multiple daily injections (MDI) group, phase-related fluctuations in TIR and TAR reached significance precisely within the CSII group. Furthermore, glycemic shifts in TAR, TBR and mean glucose were especially pronounced in adolescents with tight glycemic control (HbA1c < 7.0%). Conclusions: The late luteal phase is associated with significant glycemic deterioration in adolescent girls with T1D, particularly in those with optimal glycemic control. These findings underscore the need for targeted education and menstrual-cycle-tailored insulin dose adjustments.
- Open Access
The Rationale for Postoperative MRI Surveillance in Lobular Breast Cancer
Background/Objectives: Postoperative breast cancer imaging follow-up primarily relies on annual mammography, while magnetic resonance imaging is reserved for selected cases. Invasive lobular carcinoma has growth characteristics that can limit detection on conventional imaging and may influence recurrence patterns. This study aimed to determine whether histological type can help guide postoperative magnetic resonance imaging follow-up. Secondary objectives were to assess inter-reader agreement and evaluate timing of new breast malignancies in relation to tumor features. Methods: This retrospective, single-center study included patients with invasive breast carcinoma diagnosed during 2015 and 2016 who underwent surgery, had pre-treatment magnetic resonance imaging, at least one postoperative magnetic resonance imaging within five years, and a minimum follow-up of seven years. Clinical, pathological, and imaging data were collected. New breast malignancies included both local recurrences and second primary tumors. Two radiologists independently reviewed postoperative magnetic resonance imaging examinations in patients, and inter-reader agreement was assessed using Cohen’s kappa coefficient. Results: Seventy-seven patients with 80 tumors were included. Six patients (8%) developed a new breast malignancy. New malignancies were more common in patients with invasive lobular carcinoma (p = 0.04). Magnetic resonance imaging detected all new malignancies in patients with primary invasive lobular carcinoma, whereas mammography missed two of three cases. New breast malignancies were classified as early (within 5 years of diagnosis and initial treatment) or late (at or after 5 years); most occurred within five years, with one late occurrence at 5.6 years. Inter-reader agreement for both magnetic resonance imaging and mammographic detection showed complete concordance (κ = 1.00). Conclusions: Patients with primary invasive lobular carcinoma had a higher rate of new breast malignancies, and postoperative magnetic resonance imaging detected new malignancies missed by mammography. These findings suggest that tumor histology may be relevant when considering postoperative imaging and that patients with invasive lobular carcinoma may benefit from magnetic resonance imaging follow-up.
Open AccessThe Rationale for Postoperative MRI Surveillance in Lobular Breast Cancer
Background/Objectives: Postoperative breast cancer imaging follow-up primarily relies on annual mammography, while magnetic resonance imaging is reserved for selected cases. Invasive lobular carcinoma has growth characteristics that can limit detection on conventional imaging and may influence recurrence patterns. This study aimed to determine whether histological type can help guide postoperative magnetic resonance imaging follow-up. Secondary objectives were to assess inter-reader agreement and evaluate timing of new breast malignancies in relation to tumor features. Methods: This retrospective, single-center study included patients with invasive breast carcinoma diagnosed during 2015 and 2016 who underwent surgery, had pre-treatment magnetic resonance imaging, at least one postoperative magnetic resonance imaging within five years, and a minimum follow-up of seven years. Clinical, pathological, and imaging data were collected. New breast malignancies included both local recurrences and second primary tumors. Two radiologists independently reviewed postoperative magnetic resonance imaging examinations in patients, and inter-reader agreement was assessed using Cohen’s kappa coefficient. Results: Seventy-seven patients with 80 tumors were included. Six patients (8%) developed a new breast malignancy. New malignancies were more common in patients with invasive lobular carcinoma (p = 0.04). Magnetic resonance imaging detected all new malignancies in patients with primary invasive lobular carcinoma, whereas mammography missed two of three cases. New breast malignancies were classified as early (within 5 years of diagnosis and initial treatment) or late (at or after 5 years); most occurred within five years, with one late occurrence at 5.6 years. Inter-reader agreement for both magnetic resonance imaging and mammographic detection showed complete concordance (κ = 1.00). Conclusions: Patients with primary invasive lobular carcinoma had a higher rate of new breast malignancies, and postoperative magnetic resonance imaging detected new malignancies missed by mammography. These findings suggest that tumor histology may be relevant when considering postoperative imaging and that patients with invasive lobular carcinoma may benefit from magnetic resonance imaging follow-up.